The protective dose sits far below the psychiatric one.

That gap is why “it’s already in the water” shows correlation, not that supplements prevent dementia.

Harvard researchers found Alzheimer’s brains held less lithium, but the only human trial, of a different salt, found no benefit.

A Johns Hopkins trial of lithium orotate in early Alzheimer’s patients starts next month, running to 2029.

Sources: New Scientist